-
April 14, 2022 Numinus Acquires Novamind: What Does This Mean for the Psychedelic Industry? | NUMI, NMNuminus Acquiring Novamind in First Major Psychedelics Merger Get your 20%-off tickets to the Catalyst...
-
April 12, 2022 Numinus Acquiring Novamind in First Major Psychedelics MergerThis deal will make Numinus the psychedelic medicines company with the highest revenue, though of...
-
April 8, 2022 Psychedelic Business Spotlight – April 8This week in psychedelic business news: Field Trip Health secures a patent; Core One Labs...
-
April 7, 2022 Attend Canada’s Premiere Psychedelics Conference From Anywhere in the WorldThe 3rd annual Psychedelics Catalyst Summit at Queen’s University in Kingston, Ontario, will be available...
-
April 5, 2022 How to Legally Access Psychedelic Therapy in Canada | The Psychedelic InvestorHow can someone legally access psychedelic therapy in Canada? This is the question that I...
-
April 1, 2022 Psychedelic Business Spotlight – April 1This week in psychedelic business news: TripSitter expands; Enveric files a major patent; and Psychedelic...
-
March 28, 2022 MindMed 2021 Year-End Conference Call and Earnings: Big Updates for MNMD StockMindMed 2021 Year-End Conference Call and Earnings: Big Updates for MNMD Stock Join our Newsletter...
-
March 25, 2022 Interested in Psychedelic Stocks? This Is the BEST Resource for YouIntroducing the Benzinga Psychedelics Capital Conference on April 19 in Miami Beach,
-
March 25, 2022 Psychedelic Business Spotlight – March 25This week in psychedelic business news: Filament Health scores 2nd psilocybin patent; a new psychedelics...
-
March 24, 2022 Psilocybin Is Effective in Reducing Weight Gain, New Study ShowsNeonMind finds that its proprietary psilocybin has the ability to target visceral fat, effectively reducing...
